Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Glioma × Irinotecan × Clear all

Phase

Status

Completed 17 Terminated 5 Active not recruiting 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 50 Stomach Neoplasms 24 Rectal Neoplasms 19 Colonic Neoplasms 17 Small Cell Lung Carcinoma 11 Neoplasm Metastasis 11 Pancreatic Neoplasms 6 Locally Advanced Rectal Cancer 5 Colorectal Cancer Metastatic 5 Esophageal Neoplasms 4 Biliary Tract Neoplasms 4 Recurrence 3 Liver Neoplasms 3 Glioblastoma 3 Gastrointestinal Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Cholangiocarcinoma 3 Breast Neoplasms 3 Solid Tumors 2 Sarcoma 2 Lung Neoplasms 2 Gallbladder Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Advanced Colorectal Cancer 2 mCRC 1 Thrombocytopenia 1 Second Line Treatment of Gastric Cancer 1 Sarcoma, Ewing 1 Previously Treated Metastatic Colorectal Cancer 1 Neutropenia 1

Interventions

Temozolomide 14 Radiotherapy 7 apatinib 4 anlotinib 3 Surgical Procedures, Operative 3 Chlorotoxin 3 Positron Emission Tomography Computed Tomography 2 Pemetrexed 2 Magnetic Resonance Spectroscopy 2 Lomustine 2 Immunotherapy, Adoptive 2 Blood Specimen Collection 2 Bevacizumab 2 Aminolevulinic Acid 2 sodium thiosulfate 1 ribociclib 1 poly ICLC 1 etoposide phosphate 1 Vinblastine 1 Valproic Acid 1 Tranexamic Acid 1 Surveys and Questionnaires 1 Rivaroxaban 1 Radiosurgery 1 Radiation 1 Propofol 1 Polymerase Chain Reaction 1 Poly I-C 1 Metformin 1 Metabolism 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01144988 2011-08-02

AVIRMA01-09

Medical University Innsbruck

Phase 2 Unknown

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡